NIHR Exeter BRC PhD students publish lung disease research

University Hospitals Birmingham NHS Foundation Trust (UHB) has treated the first patient in an early-phase clinical trial investigating whether a new medical device, Carbalive, can slow disease progression of a rare liver disease called primary sclerosing cholangitis (PSC). Coordinated by clinicians at Queen Elizabeth Hospital Birmingham (QEHB) in collaboration with researchers at the University of Birmingham and the NIHR Birmingham Biomedical Research Centre (BRC), this trial marks the first time will be studied in humans. We are proud to have funded this trial through a Pathfinder award, one of 6 awards made to UK universities to fund translational science. It's another great example of promising science that could positively change the lives of people with a rare disease.

According to research published by JAMA Internal Medicine, 30% of Black M.D.-Ph.D. candidates enrolled from 2004 to 2012 did not complete their training compared to 17% of their white counterparts. https://trib.al/JVOdZqP

According to research published by JAMA Internal Medicine, 30% of Black M.D.-Ph.D. candidates enrolled from 2004 to 2012 did not complete their training compared to 17% of their white counterparts.

Celebrating excellence in medical science. Eight Harvard Medical School faculty members have been elected to the National Academy of Medicine — a recognition of groundbreaking work spanning immunology, microbiome research, diabetes, neurology, pediatrics, and beyond. From decoding how our immune system defends itself to transforming cancer, diabetes, and neurological care, their work reflects the best of what science can offer: discovery that saves lives. Pioneering today’s breakthroughs to shape tomorrow’s medicine. #MedicalInnovation #BiomedicalResearch #HealthcareLeadership #HarvardMedicalSchool #ScienceForHealth

Today, Europe faces a pressing gap in consistent, standardised, and high-quality simulation training for healthcare professionals across all medical specialties.   The newly launched EU-funded ERIS project sets out to change that. Its goal is to establish and validate the first European Research Institute on Simulation (ERIS), an educational institution at the European level built on a collaborative academic network focused on training healthcare professionals in interventional electrophysiology.   “The ageing population is significantly increasing the demand for healthcare, driving growth in the healthcare market,” says ERIS project coordinator Professor Serge Boveda, co-head of the Cardiac Arrhythmia Management Department at the Clinique Pasteur Toulouse, France.   Cardiovascular diseases are responsible for nearly 45% of all deaths in Europe. As the population continues to age, the demand for advanced, simulation-based medical training is increasing, particularly in electrophysiology, a rapidly expanding field that addresses heart rhythm disorders.   Read more about the project in our press release: https://lnkd.in/gWdmAvB8   #cvhealth #hearthealth #PublicHealth European Society of Cardiology

Brand new publication by a Faculty of Health, Medicine and Society student and staff! Vicky Hughes, Dr Hazel M. Chapman, and Dr Tracy Ross, have had their paper “Person-centred care in the management of imaging-related anxiety in diagnostic radiography: A scoping review exploring cancer and non-cancer populations" published in 'Radiography'. Vicky is the Professional Lead for Diagnostic Radiography at the University of Liverpool, and we are very proud that she has chosen to undertake her professional doctorate with us and is leading the way in this challenging but fundamental aspect of radiography service development and patient provision! Hazel and Tracy are both Lecturers at the University of Chester within the division of Nursing. The paper explores the research literature around anxiety related to diagnostic imaging (scans and X-rays), particularly for people with a potential diagnosis of cancer. Read for yourself via the link below: https://lnkd.in/eF7JJWCH #UniOfChester #UOCFHMS #studentpublication

Dr. Susan Storey's research explores how significant fluctuations in blood glucose levels, known as glycemic variability, are affecting the long-term health of cancer survivors with Type 2 diabetes. Although glycemic variability remains an understudied area in cancer survivorship research, Storey and her research team—which includes PhD students making meaningful contributions through cutting-edge, interdisciplinary research—are currently exploring questions that will help inform future clinical practice. Learn more about Dr. Storey's research, and discover if pursuing a PhD in Nursing Science at the IU School of Nursing is right for you: https://ow.ly/JgQr50XqIyL

💡 What does it take to shape the future of cardiovascular medicine? For Dr. Robert Bonow, it’s a lifetime of leadership, research, and innovation. Dr. Bonow, the Goldberg Distinguished Professor of Cardiology at Northwestern University Feinberg School of Medicine, has dedicated his career to advancing cardiovascular medicine through groundbreaking research, education, and leadership. As Vice Chairman of the Department of Medicine and Director of the Center for CardioVascular Innovation , Dr. Bonow continues to influence the next generation of clinicians and scientists. Prior to his leadership at Northwestern, he served as Senior Investigator and Deputy Chief of the Cardiology Branch at the The National Institutes of Health’s National Heart, Lung, and Blood Institute. Dr. Bonow has authored more than 500 scientific papers and 100 book chapters and is one of the four editors of Braunwald’s Heart Disease, the world’s leading cardiology textbook. His impact extends across the American Heart Association and American College of Cardiology, where he has served as president and earned multiple distinguished awards for leadership and scientific excellence. An endowed chair established in his name at Northwestern honors his lasting contributions to cardiovascular medicine, and he continues to advance the field of translational medicine as a Governing Board member of the International Society for Cardiovascular Translational Research. 💭 How can medical education and leadership continue to inspire innovation in cardiovascular care today? ❤️ Visit our site to learn more about the ISCTR's work and the people who make our mission a reality! https://isctr.org/ #Cardiology #MedicalInnovation #Leadership #HealthcareEducation #NorthwesternMedicine #entrepreneurship #medtech

On Thursday 16 October 2026, the first management committee meeting of a new Europe-wide research consortium was held in Brussels at the offices of the COST Association - European Cooperation in Science and Technology, marking the official start of this ambitious initiative. The meeting was hosted by COST and is coordinated by Queen Mary University of London. The consortium, announced in June 2025, is funded through a highly competitive COST grant and brings together researchers, industry experts, and public-sector partners from across Europe and beyond. Coordinated by Queen Mary, the network brings together more than 250 experts from over 50 institutions in 40 countries, reflecting the University’s growing leadership in European scientific collaboration. The network focuses on the emerging field of resolution biology, which explores how the body resolves inflammation and restores tissue function to health. By bringing together experts from different fields, the network aims to foster multidisciplinary research and training to accelerate scientific discovery and clinical translation. With the network now formally convened, partners will embark on a range of collaborative projects, joint training programmes, and knowledge-exchange activities designed to strengthen Europe’s research capacity in this field. Professor Jesmond Dalli from Queen Mary University of London, said: "This network represents an exciting new chapter for the field of resolution biology. By uniting leading scientists, clinicians, industry partners, and patient representatives from across Europe, we are creating a unique platform to accelerate discovery and innovation — transforming how we understand and treat chronic inflammatory diseases. It’s a privilege to lead such a dynamic and collaborative community committed to advancing science that restores health rather than simply suppressing disease. As we embark on this journey, we warmly welcome new experts, stakeholders, and especially young researchers to join us in shaping the future of this rapidly evolving field." The COST framework plays a pivotal role in supporting pan-European research networks, enabling scientists to connect, share expertise, and build capacity across disciplines and borders. Queen Mary’s coordination of this initiative underscores the University’s commitment to international collaboration and research excellence. Further information: Queen Mary University of London to lead EU-wide Resolution Biology network https://lnkd.in/esnKhqn4 Read more about the newly approved COST Actions https://lnkd.in/d9hCJT7W Queen Mary Faculty of Medicine and Dentistry

Dr Andrew Boyle from the Wellcome-Wolfson Institute for Experimental Medicine at Queen’s has been awarded a prestigious fellowship to lead a UK-wide intensive care clinical trial. The Efficacy and Mechanism Evaluation Advanced Fellowship from the National Institute for Health and Care Research recognises researchers demonstrating exceptional promise and leadership in health and care research. The Fellowship will enable Dr Boyle to further his groundbreaking research into acute respiratory distress syndrome (ARDS) by leading a new UK-wide clinical trial which has the potential to identify the first drug treatment to work for patients with the condition. Find out more: ow.ly/usvf50XrevJ